Global NewsNews

Lupin launches authorised generic version of Duexis in US

Indicated for the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis

Lupin announced the launch of the authorised generic version of Duexis (ibuprofen and famotidine) Tablets, 800 mg/26.6 mg, of Horizon Medicines.

THIS CAN BE YOUR ADVERTISEMENT

Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg, are indicated for the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers, which in the clinical trials was defined as a gastric and/or duodenal ulcer in patients who are taking ibuprofen for those indications.

Ibuprofen and Famotidine Tablets (RLD: Duexis) had estimated annual sales of $765 million in the US (IQVIA MAT July 2021).

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close